A proposal for developing a large patient population cohort for longterm safety monitoring in rheumatoid arthritis

Journal of Rheumatology

Volumn 28, Issue 5, 2001, Pages 1170-1173

  Lipani, J A ^a   Strand, V ^a   Johnson, K ^a   Woodworth, T ^a   Furst, D ^a   Singh, G ^a   Day, R ^a   Brooks, P ^a  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

Adverse; Database; Effects; Registry; Safety; Surveillance; Toxicity

Indexed keywords

ANTIRHEUMATIC AGENT;

CONFERENCE PAPER; DATA BASE; DRUG MONITORING; DRUG SAFETY; HUMAN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CLINICAL TRIALS; COHORT STUDIES; HUMANS; REGISTRIES;

EID: 0035007056     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (24)

1. Lymphomas during long-term methotrexate therapy
2. Incidence of cancer among patients with rheumatoid arthritis
3. Incidence of cancer among men with the Felty syndrome
4. Lymphoma and leukemia in RA: A matched case control study in the ARAMIS population
5. Members of RAAR steering committee. The Rheumatoid Arthritis Azathioprine Registry (RAAR) -interim analysis of malignancy and mortality
6. Excess mortality in rheumatoid arthritis - Is it the disease or the drugs?
7. Cause of death in patients with RA with particular reference to azathioprine
8. Lymphoproliferative cancer and other malignancy in RA patients treated with azathioprine: A 20 year follow up study
9. Toxic effects of azathioprine in rheumatoid arthritis: A national post-marketing perspective
10. Death attributed to antirheumatic medication in a nationwide series of 1666 patients with rheumatoid arthritis who have died
11. The risk of neoplasms in patients treated with cyclosporine A
12. Malignancies in rheumatoid arthritis patients treated with cyclosporine A
13. Epstein Barr virus associated Hodgkin's lymphoma in a rheumatoid arthritis patient treated with methotrexate and cyclosporine A
14. Lymphoma in patients with rheumatoid arthritis: Association with disease state or methotrexate treatments
15. Is methotrexate oncogenic in patients with rheumatoid arthritis?
16. Epstein Barr virus associated lymphoproliferative disease during methotrexate therapy for psoriasis
17. No increase in second tumours after cytotoxic chemotherapy for gestational trophoblastic tumors
18. Clinical response of RA to anti-TNIa (cA2) monoclonal antibody is related to administered dose and persistence of circulating antibody
19. Monoclonal antibody therapy in rheumatoid arthritis - An update on recent progress
20. The experience with CAMPATH 1H
21. Comparative toxicity of non-steroidal anti-inflammatory agents
22. Reduction in long-term disability in patients with rheumatoid arthritis by disease modifying anti-rheumatic drug based treatment strategies
23. Risk of developing certain malignancies is related to duration of immunosuppressive drug exposure in patients with rheumatic diseases